Catalent is excited to participate in the 2025 Drug Delivery & Formulation (DDF) Summit, a premier event uniting global experts to explore the latest advances and challenges in drug delivery and formulation. The summit offers a key platform for sharing innovation and fostering collaboration across the pharmaceutical industry.

Date: June 2-4, 2025
Location: Berlin

JOIN US!

Meet with Catalent experts to gain key insights on overcoming drug product development and manufacturing challenges for oral bifunctional targeted protein degraders.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Poster Presentation
Lipid-based Formulations in Softgel Development – A Designed Approach
Guillaume Enderlin, Associate Director Product Development
Frieder Helm, Senior Formulation Scientist, Product Development

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.

 

 

More products. Better treatments. Reliably supplied.™